Volume 18, Issue 12 (December 2020)                   IJRM 2020, 18(12): 1065-1072 | Back to browse issues page


XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Wiweko B, Afdi Q F, Harzif A K, Pratama G, Sumapraja K, Muharam R, et al . Analysis of factors associated with ovarian reserve in a group of poor responders to in vitro fertilization: A cross-sectional study. IJRM 2020; 18 (12) :1065-1072
URL: http://ijrm.ir/article-1-1607-en.html
1- Department of Obstetrics and Gynecology, Division of Reproductive Endocrinology and Infertility, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia. Yasmin IVF Clinic, Dr. Cipto Mangunkusumo General Hospital, Jakarta, Indonesia. Human Reproductive, Infertility and Family Planning Research Center, Indonesia Medical Education and Research Institute (IMERI), Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia. , wiwekobudi@yahoo.co.id
2- Department of Obstetrics and Gynecology, Division of Reproductive Endocrinology and Infertility, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia.
3- Department of Obstetrics and Gynecology, Division of Reproductive Endocrinology and Infertility, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia. Yasmin IVF Clinic, Dr. Cipto Mangunkusumo General Hospital, Jakarta, Indonesia. Human Reproductive, Infertility and Family Planning Research Center, Indonesia Medical Education and Research Institute (IMERI), Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia.
Full-Text [PDF 277 kb]   (660 Downloads)     |   Abstract (HTML)  (3594 Views)
Full-Text:   (444 Views)
  1. Introduction

Infertility are generally classified into good and poor responder. Assisted reproductive technology (ART) is a medical procedure used to treat infertility by directly manipulating oocytes outside the body. One of the most common types of ART is in vitro fertilization (IVF) (1). Approximately 9-24% of women are poor responders, and this number has increased in the last decade (2). Some study have shown that poor responders are at risk of developing pregnancy complications, such as hypertension and preeclampsia, due to low-quality embryo (3, 4). About 56% of sub fertile couples worldwide undergo IVF, with a success rate of 30-40% (5). In 2011, 2,627 IVF cases from 14 IVF clinics were recorded in Indonesia, with a success rate of 38.5% (6). According to the Yasmin Clinic Dr. Cipto Mangunkusumo National General Hospital (RSCM), 318 IVF cycles were recorded in 2013 and 551 cycles in 2014. Participants as much as 39 women were recorded as poor responders in 2013 and 24 women in 2014 (7, 8).
Response to ovarian stimulation by examining ovarian reserve is important to determine the success of ART (9). The poor-responder group is a group of participants who have ≤ 3 oocytes after ovarian stimulation (10). In 2011, the Bologna criteria indicated that a poor responder must meet two of the three criteria, which include age > 40 yr or presence of risk factors, antral follicle count (AFC) < 6-8 follicles per ovary or anti-Müllerian hormone (AMH) level < 0.5-1.1 ng/mL, and a history of producing ≤ 3 oocytes after ovarian stimulation (2). However, Poseidon classification is the current criteria recommended by the European Society of Human Reproduction and Embryology (ESHRE) guideline. Ovarian reserve marked by low quantity of oocytes is associated with the quality of IVF outcomes. Ovarian reserve refers to the number, size, and quality of primordial follicles in the ovary and the reproductive potential of each oocyte (11). The best parameters to identify ovarian reserve conditions are age, AMH level, and AFC (12). An association was observed between AMH level and the number of follicles in the ovary. A study in Indonesia has shown that an AMH level of 1.40 µg/mL and AFC at 7 is the cut-off values used to predict good response and ovarian condition (13).
Ovarian reserve is typically affected by various factors such as age, body mass index (BMI), endometriosis, history of ovarian surgery, chemotherapy, and radiotherapy (14-16). Participants at 35 yr of age affect the low number and quality of primordial follicles, thereby affecting ovarian reserve and infertility (14). In addition, BMI also affects the ovarian reserves by changing the metabolism and hormone level of women (17). Moreover, a history of ovarian surgery can reduce ovarian reserve due to vascular injury, infection after surgery, and micro thromboembolism (14). Endometriosis is the other factor affecting ovarian reserves particularly in young participants (18). The association between decreased ovarian reserve and endometriosis caused by chronic inflammation that affects dormant follicles in the ovarian cortex has also been reported (19).
This study aimed to determine the most significant factors affecting poor ovarian response and the severity of the effect on decreased ovarian reserve based on the Poseidon group classifications. The first objective of this study was to find the most significant association between the six independent variables- that is age, BMI, endometriosis, endometriosis location, history of ovarian surgery, and AMH- and poor-responder participants women. The second goal was to find some association between each Poseidon group and three independent variables as the factors, that is BMI, history of surgery, and endometriosis.
 

  1. Materials and Methods

This cross-sectional study was conducted from January 2013 to June 2017. Data were obtained by consecutive sampling. Participants data, such as age, BMI, endometriosis, and history of ovarian surgery, were obtained from medical records. Women who had undergone controlled ovarian stimulation protocol of IVF using gonadotropin, those who were assessed for ovarian reserve based on the number of oocytes via ovum pick-up, and those classified as good and poor responders were included. However, women with infertility due to congenital or anatomical abnormality were excluded from the study.
In this study, participants were divided into good and poor responder groups based on the ovarian reserve test; participant with oocyte ≤ 3 was classified as a poor responder. Based on this, 188 participants with nine (4-47) oocytes were included in the poor responder group. While, good responder comprised of two (0-3) oocytes. Then, based on the Poseidon criteria- which is the criteria of poor responder risk factor, the poor-responder participants were classified. The Poseidon criteria comprised into four groups, as shown in Table I.
 

  1. 1. Antagonist protocol

Gonadotropin injection was started on day 2 or 3 of the period with initial doses between 300 and 375 IU. Meanwhile, GnRH antagonist was injected 0.25 mg daily starting on day 6 of the stimulation or when the diameter of the leading follicle was 14 mm. Ovulation trigger with rhCG 250 ug was initiated when at least three follicles reached a diameter of ≥ 17 mm. Ovum pick-up was done approximately 36 hr after oocyte maturation which was triggered with rhCG.
 

      2.  2. Ethical consideration
This study was approved by the ethics committee of the Faculty of Medicine on August 06, 2018 (reference number: 0781/UN2.F1/ETHIC/2018). Informed consent was obtained from all participants before study enrollment.
 

  1. 3. Statistical analysis

Data were analyzed via bivariate tests using Chi-square test and Mann-Whitney U-test, and a multivariate analysis using linear regression was conducted to assess factors that lead most to the low ovarian reserve in poor-responder participants. A p-value < 0.05 was considered as statistically significant. Confidence interval 95% (CI 95%) was the benchmark to evaluate the data. Data were analyzed using the Statistical Package for the Social Sciences software version 20.0, SPSS Inc, Chicago, Illinois, USA (SPSS).
 

  1. Results

    1. 1. Characteristics of the participants

A total of 749 participants underwent ovarian stimulation and met the eligibility criteria from 2013 to 2017. Based on the Poseidon criteria, 262 (35%) participants were included in the non-Poseidon group, seven (0.9%) in the Poseidon 1a group, 64 (8.5%) in the Poseidon 1b, 30 (4%) in the Poseidon 2a, 113 (15.1%) in the Poseidon 2b, 73 (9.8%) in the Poseidon 3, and 200 (26.7%) in the Poseidon group 4.
Table II presents the characteristics of participants based on ovarian reserve test. Based on the number of oocytes, 188 (25%) participants were included in the poor-responder and 561 (75%) in the good-responder groups. The age of the poor-responder participants was 38.5 (25-50) years, primary infertility was reported in 170 (90.4%) respondents, the average durations of infertility was 8 yr (range: 1-23), the average BMI was 23.37 kg/m2, the average number of oocytes was 2 (0-2), and the average AMH levels were 0.55 (0.01-4.65). In this study, a majority of the, that is, 135 (71.8%) participants, did not have endometriosis. The main location of endometriosis was in the ovarium in 30 (56.6%) participants. Most participants in both groups did not have a history of ovarian surgery - 164 (87.2%) participants in the poor-responder group.
 

  1. 2. Relationship between some factors and poor ovarian response according to oocyte count

The association between age, BMI, endometriosis, and history of ovarian surgery with poor-responder group are presented in Table III.
It is also shows that age ≥ 35 yr was a significantly strong risk factor in poor-responder group. Furthermore, endometriosis was twice as a higher risk factor for them. However, no association was observed between the location of endometriosis and the poor responders (p = 0.105). A history of ovarian surgery was significantly 2.3 times higher a risk factor for poor responders. However, further analysis using logistic regression, which included AMH as an additional cofounding factor, showed that only age (p = 0.004) and AMH level (p < 0.001) were significantly associated with the poor-responder group. Meanwhile, BMI, endometriosis, and history of ovarian surgery were not significantly associated with the incidence of poor-response. Table IV shows the multivariate analysis of each Poseidon group. Endometriosis was a significant predictor of classification under Poseidon groups 1 and 4 - with an odds ratio of 2.5 and 2.7, respectively. A history of ovarian surgery was a significant determinant of inclusion in Poseidon groups 2 and 3 (p < 0.05), whereas an increase in BMI decreased the risk of inclusion in Poseidon group 3.



      4. Discussion
In this study, an association between age ≥ 35 yr and poor responder was observed. A total of 78.2% participants aged ≥ 35 yr were at 3.1 (2.1-4.5) times higher risk for poor response than those aged < 35 yr. Several studies have used age ≥ 40 yr as a predictor of poor response. Whereas, some have used a cut-off value of 35 yr (Poseidon group) (14, 21). An increase in the BMI decreased the risk to be classified under Poseidon group 3. Halawaty and colleagues showed insignificant difference between obese and nonobese participants in terms of age, serum AMH level, serum FSH level, fasting blood glucose level, 2-h post-prandial blood glucose level, and AFC (22). Additionally, an increase in BMI was correlated to polycystic ovarium syndrome (PCOS) and higher AMH levels. Some study showed that most obese participants with PCOS had higher AMH level and metabolic disruption (23, 24). Therefore, an increase in BMI decreases the risk of poor response.
In terms of BMI, the poor-responder group had a higher BMI than the good-responder group. However, the result was not significantly different (p > 0.05). The association between obesity and ovarian reserve remains controversial. A study showed the negative effects of obesity on ovarian reverses (25). De Pergola et al explained that the follicle-stimulating hormone (FSH), luteinizing hormone (LH), inhibin B, and estradiol levels in women of reproductive age, who are either overweight or obese, were lower than those of women with normal weight in the early follicular phase due to the inhibitory effect of body mass on gonadotropin and estradiol production (26). However, several studies have shown that obesity is not associated with AFC. Moreover, lower AMH levels in obese women of reproductive age are attributed to physiological process and does not decrease the ovarian reserve (25-27).
In this study, endometriosis was significantly associated with poor responders (p < 0.001). The participants with endometriosis were at 2.0 (1.3-2.9) times higher risk to be a poor responder than those without. However, no association was observed between the location of endometriosis and poor response (p > 0.05). A small study reported that 34 women with endometriosis had lower AMH levels than those with infertility due to tubal factors (1.26 vs 2.02 ng/mL; p = 0.004) (28). Dokras and co-authors founded that inhibin B level was significantly lower in women with endometriosis than those without during gonadotropin stimulation (29). Hwu and colleagues and Uncu and co-workers also reported that the serum AMH level of women with endometriosis was significantly lower than the control group. However, they diagnosed endometriosis only by ultrasonography (30, 31). According to the Poseidon criteria, endometriosis was a significant predictor for Poseidon group 1. The participants with endometriosis were at 2.5 times higher risk to be classified under Poseidon groups 1 and 4 (95% CI: 1.5-5.2). Theoretically, endometriosis reduces ovarian reserve due to its inflammatory effects on the ovarian cortex based on serum AMH levels. The density of ovarian cortex in women with endometriosis decreases due to the formation of fibrotic tissues (32). A study showed that endometriosis cause a decrease in serum estradiol levels and production of LH-dependent progesterone (33).
Interestingly, a significant association was observed between a history of ovarian surgery and poor response (p < 0.05). Participants with a history of ovarian surgery were at 2.3 times higher risk to be poor responder (95% CI: 1.3-4.1). Lind and colleagues assessed the effect of cyst removal on ovarian reserve by measuring serum AMH levels (34). Another study also reported about a continuous decreased in serum AMH levels from 2.7 µg/L to 2.0 µg/L at a six-month follow-up after surgery and to 1.0 µg/L at two-year follow-up (34). A history of ovarian surgery was a significant predictor of classification under Poseidon groups 2 and 3. The participants with a history of ovarian surgery were at 4.6 times higher risk for poor response (95% CI: 1.5-13.9) than those without. The results of this study were similar to those of other studies showing a continuous decrease in serum AMH levels from 2.7 µg/L to 2.0 µg/L at a six-month follow-up after surgery and to 1.0 µg/L at a two-year follow-up (34).
 
       5. Conclusion
Significant differences were observed in terms of age, endometriosis, and history of ovarian surgery in the poor-responder group. Endometriosis was a significant predictor of classification under Poseidon groups 1 and 4, and a history of ovarian surgery was a significant predictor of classification under Poseidon groups 2 and 3. Furthermore, BMI was a significant predictor of classification under Poseidon group 3. Age, BMI, endometriosis, and history of ovarian surgery were associated with ovarian reserve in the poor-responder group.
 
Acknowledgments
The authors thank to Dr. Cipto Mangunkusumo General Hospital and Yasmin IVF Clinic. This study does not have any financial support.
 
Conflict of interest
The authors declare that they have no competing interests.
 

Type of Study: Original Article | Subject: Fertility & Infertility

References
1. Stern K. Assisted reproductive technology: What's new and what's important? Aust Fam Physician 2012; 41: 762-768.
2. Ferraretti AP, Marca AL, Fauser B, Tarlatzis B, Nargund G, Gianaroli L. ESHRE consensus on the definition of "poor response" to ovarian stimulation for in vitro fertilization: The bologna criteria. Hum Reprod 2011; 26: 1616-1624. [DOI:10.1093/humrep/der092] [PMID]
3. Liu KE, Case A. Advanced reproductive age and fertility. J Obstet Gynaecol Can 2011; 33: 1165-1167. [DOI:10.1016/S1701-2163(16)35087-3]
4. Disseldorp JV, Eijkemans R, Fauser B, Broekmans F. Hypertensive pregnancy complications in poor and normal responders after in vitro fertilization. Fertil Steril 2010; 93: 652-657. [DOI:10.1016/j.fertnstert.2009.01.092] [PMID]
5. Mouzon Jd, Goossens V, Bhattacharya S, Castilla JA, Ferraretti AP, Korsak V, et al. Assisted reproductive technology in Europe, 2006: Results generated from European registers by ESHRE. Hum Reprod 2010; 25: 1851-1162. [DOI:10.1093/humrep/deq124] [PMID]
6. PERFITRI. Laporan IVF di Indonesia [unpublished organization report]. Perhimpunan Fertilisasi In Vitro Indonesia; 2012.
7. Yasmin IVF Clinic. Laporan Tahunan Klinik Yasmin [unpublished clinic report]. Klinik Yasmin, Dr.Cipto Mangunkusumo General Hospital; 2014.
8. Yasmin IVF Clinic. Laporan Tahunan Klinik Yasmin [unpublished clinic report]. Klinik Yasmin, Dr.Cipto Mangunkusumo General Hospital; 2015.
9. Fauser BCJM, Diedrich K, Devroey P, Evian Annual Reproduction Workshop Group 2007. Predictors ov ovarian response: Progress towards individualized treatment in ovulation induction and ovarian stimulation. Hum Reprod Update 2008; 14: 1-14. [DOI:10.1093/humupd/dmm034] [PMID]
10. Broekmans FJ, Kwee J, Hendriks DJ, Mol BW, Lambalk CB. A systematic review of tests predicting ovarian reserve and IVF outcome. Hum Repod Update 2006; 12: 685-718. [DOI:10.1093/humupd/dml034] [PMID]
11. Broekmans FJ, Knauff EAH, te Velde ER, Macklon NS, Fauser BC. Female reproductive ageing: Current knowledge and future trends. Trends Endocrinol Metab 2007; 18: 58-65. [DOI:10.1016/j.tem.2007.01.004] [PMID]
12. Findlay JK, Hutt KJ, Hickey M, Anderson RA. What is the "ovarian reserve"? Fertil Steril 2015; 103: 628-630. [DOI:10.1016/j.fertnstert.2014.10.037] [PMID]
13. Wiweko B, Hestiantoro A, Sumapraja K, Natadisastra M, Febia E, Andriyana H, et al. Anti mullerian hormone serum level indicates ovarian response in controlled ovarian hyperstimulation of IVF Cycles. Indones J Obstet Gynecol 2010; 34: 114-118.
14. Padhy N, Gupta S, Mahla A, Latha M, Varma T. Demographic characteristic and clinical profile of poor responders in IVF/ ICSI: A comparative study. J Hum Reprod Sci 2012; 3: 91-94. [DOI:10.4103/0974-1208.69343] [PMID] [PMCID]
15. Ubaldi F, Vaiarelli A, D Anna R, Rienzi L. Management of poor responders in IVF: Is there anything new? BioMed Res Int 2014; 2014: 1-11. [DOI:10.1155/2014/352098] [PMID] [PMCID]
16. Fritz MA, Speroff L. Clinical gynecology endocrinology and infertility. Philadelphia: Lippincott Williams & Wilkins; 2011: 107-113.
17. Pasquali R, Pelusi C, Genghini S, Cacciari M, Gambineri A. Obesity and reproductive disorders in women. Hum Reprod Update 2003; 9: 359-372. [DOI:10.1093/humupd/dmg024] [PMID]
18. Kitajima M, Defrere S, Dolmans MM, Colette S, Squifflet J, Langendonckt AV, et al. Endometriomas as a possible cause of reduced ovarian reserve in women with endometriosis. Fertil Steril 2011; 96: 685-691. [DOI:10.1016/j.fertnstert.2011.06.064] [PMID]
19. Kitajima M, Masuzaki H. Ovarian reserve in patients with endometriosis. In Harada T, editor. Endometriosis: Pathogenesis and Treatment. 26th chapter. Japan: Springer; 2014. 419-429. [DOI:10.1007/978-4-431-54421-0_26]
20. Alviggi C, Andersen CY, Buehler K, Conforti A, De Placido G, Esteves SC, et al. A new more detailed stratification of low responders to ovarian stimulation: from a poor ovarian response to a low prognosis concept. Fertil Steril 2016; 105: 1452-1453. [DOI:10.1016/j.fertnstert.2016.02.005] [PMID]
21. Humaidan P, Alviggi C, Fischer R, Esteves SC. The novel POSEIDON stratification of ' Low prognosis patients in Assisted Reproductive Technology' and its proposed marker of successful outcome. F10000Res 2016; 5: 2911-2921. [DOI:10.12688/f1000research.10382.1] [PMID] [PMCID]
22. Halawaty S, ElKattan E, Azab H, ElGhamry N, Al-Inany H. Effect of obesity on parameters of ovarian reserve in premenopausal women. J Obstet Gynaecol Can 2010; 32: 687-690. [DOI:10.1016/S1701-2163(16)34573-X]
23. Wiweko B, Maidarti M, Priangga MD, Shafira N, Fernando D, Sumapraja K, et al. Anti-mullerian hormone as a diagnostic and prognostic tool for PCOS patients. J Assist Reprod Genet 2014; 31: 1311-1316. [DOI:10.1007/s10815-014-0300-6] [PMID] [PMCID]
24. Fruzzetti F, Perini D, Lazzarini V, Parrini D, Genazzani AR. Adolescent girls with polycystic ovary syndrome showing different phenotypes have a different metabolic profile associated with increasing androgen levels. Fertil Steril 2009; 92: 626-634. [DOI:10.1016/j.fertnstert.2008.06.004] [PMID]
25. Freeman EW, Gracia CR, Sammel MD, Lin H, Lim LCL, Strauss JF. Association of AMH levels with obesity in late reproductive age women. Fertil Steril 2007; 87: 101-106. [DOI:10.1016/j.fertnstert.2006.05.074] [PMID]
26. De Pergola G, Maldera S, Tartagni M, Pannacciulli N, Loverro G, Giorgino R. Inhibitory effect of obesity on gonadotropin, estradiol, and inhibin B Levels in fertile women. Obesity (Silver Spring) 2006; 14: 1954-1960. [DOI:10.1038/oby.2006.228] [PMID]
27. Su HI, Sammel MD, Freeman EW, Lin H, DeBlasis T, Gracia CR. Body size affects measures of ovarian reserve in late reproductive age women. Menopause 2008; 15: 857-861. [DOI:10.1097/gme.0b013e318165981e] [PMID] [PMCID]
28. Lemos NA, Arbo E, Scalco R, Weiler E, Rosa V, Cunha-Filho JS. Decreased antimüllerian hormone and altered ovarian follicular cohort in infertile patients with mild/minimal endometriosis. Fertil Steril 2008; 89: 1064-1068. [DOI:10.1016/j.fertnstert.2007.04.048] [PMID]
29. Dokras A, Habana A, Giraldo J, Jones E. Secretion of inhibin B during ovarian stimulation is decreased in infertile women with endometriosis. Fertil Steril 2000; 74: 35-40. [DOI:10.1016/S0015-0282(00)00568-9]
30. Hwu YM, Wu FSY, Li SH, Sun FJ, Lin MH, Lee RKK. The impact of endometrioma and laparoscopic cystectomy on serum anti-Mullerian hormone levels. Reprod Biol Endocrinol 2011; 9: 80-87. [DOI:10.1186/1477-7827-9-80] [PMID] [PMCID]
31. Uncu G, Kasapoglu I, Ozerkan K, Seyhan A, Oral Yilmaztepe A, Ata B. Prospective assessment of the impact of endometriomas and their removal on ovarian reserve and determinants of the rate of decline in ovarian reserve. Hum Reprod 2013; 28: 2140-2145. [DOI:10.1093/humrep/det123] [PMID]
32. Kitajima M, Newaz Khan K, Harada A, Taniguchi K, Inoue T, Kaneuchi M, et al. Association between ovarian endometrioma and ovarian reserve. Front Biosci 2018; 10: 92-102. [DOI:10.2741/e810] [PMID]
33. Practice Committee of the American Society for Reproductive Medicine. Endometriosis and infertility: a committee opinion. Fertil Steril 2012; 98: 591-598. [DOI:10.1016/j.fertnstert.2012.05.031] [PMID]
34. Lind T, Hammarström M, Lampic C, Rodriguez-Wallberg K. Anti-Müllerian hormone reduction after ovarian cyst surgery is dependent on the histological cyst type and preoperative anti-Müllerian hormone levels. Acta Obstet Gynecol Scand 2015; 94: 183-190. [DOI:10.1111/aogs.12526] [PMID]

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Designed & Developed by : Yektaweb